Central centrifugal cicatricial alopecia, known as CCCA, is a progressive form of scarring hair loss that begins at the crown or center of the scalp and spreads outward. It predominantly affects women of African descent, with prevalence estimates ranging from about 3% to nearly 6% in this group, and it can cause permanent destruction of hair follicles if left untreated.1PubMed. Central Centrifugal Cicatricial Alopecia: New Insights and a Call for Action The condition has both genetic and environmental contributors, and while there is no cure, early treatment can slow its progression and sometimes restore some hair growth.
Who Gets CCCA
CCCA is seen most often in middle-aged women of African descent. Studies in the United States have found that among adult Black women, about 2.7% had clinically evident central hair loss consistent with CCCA when schoolgirls were excluded from the count.2JAMA Dermatology. Prevalence of Central Centrifugal Cicatricial Alopecia Other population-based surveys have reported higher rates, with one study finding that 28% of participants had some degree of central hair loss and that more than half of those met the clinical threshold for CCCA.3Archives of Dermatology. Medical and Environmental Risk Factors for the Development of Central Centrifugal Cicatricial Alopecia: A Population Study These differences likely reflect how each study defined clinical cutoffs and recruited its participants, but the overall picture is consistent: CCCA is common and underrecognized.
Although CCCA is overwhelmingly diagnosed in women, men can develop it too. Case reports have documented biopsy-confirmed CCCA in African American men with vertex hair loss and scalp symptoms, a presentation that is easily mistaken for ordinary male-pattern baldness.4PubMed Central. Differentiating central centrifugal cicatricial alopecia and androgenetic alopecia in african american men: report of three cases Because the condition is so closely associated with women, men with CCCA often go undiagnosed for years.
Symptoms and How the Condition Progresses
CCCA typically starts at the vertex, the highest point of the scalp, or just behind it. The hair loss fans outward in a roughly circular pattern, which is what “centrifugal” refers to. Early on, the affected area may look like mild thinning that could be passed off as normal aging. But unlike ordinary thinning, the follicle openings themselves disappear, leaving the scalp in the center of the patch smooth and sometimes shiny.5PubMed Central. A case of rapid progression of central centrifugal cicatricial alopecia after COVID-19 infection
Many people with CCCA experience symptoms beyond visible hair loss. Burning, itching, tenderness, and flaking on the scalp are all commonly reported, and in some cases these sensations precede noticeable thinning by months or even years.5PubMed Central. A case of rapid progression of central centrifugal cicatricial alopecia after COVID-19 infection These symptoms are signs that inflammation is actively damaging the follicles below the surface. Some people, however, have no symptoms at all and only discover the problem when the bald area becomes large enough to notice visually. The absence of pain or itching does not mean the disease is inactive.
Because the scarring replaces the follicular structures with fibrous tissue, any hair lost in an area where the follicles have been fully destroyed will not grow back on its own. This is what distinguishes scarring alopecias like CCCA from non-scarring types, where the follicle remains intact and regrowth is at least theoretically possible.
What Causes CCCA
Researchers now view CCCA as a condition driven by multiple factors acting together rather than a single cause. The most significant genetic finding to date involves the PADI3 gene. A landmark study found mutations in PADI3 in about a third of patients in an initial cohort. These mutations led to reduced expression of the PADI3 enzyme, abnormal positioning of the protein inside cells, and decreased enzymatic activity. Across a broader analysis, PADI3 mutations were significantly more common in women with CCCA than in control subjects of the same ancestry.6PubMed. Variant PADI3 in Central Centrifugal Cicatricial Alopecia
PADI3 plays a role in shaping the inner root sheath of the hair follicle, the structural sleeve that guides a growing hair strand upward through the skin. When the enzyme malfunctions, the inner root sheath can break down prematurely, leaving the hair shaft exposed to the surrounding tissue and triggering inflammation. The same gene has been linked to an entirely different hair disorder, uncombable hair syndrome, which is characterized by wiry, unmanageable hair in children.7PubMed Central. Deimination in epidermal barrier and hair formation The two conditions look nothing alike clinically, but both trace back to problems with how hair-forming structures are built at the molecular level.
That said, PADI3 mutations are not found in every person with CCCA, so genetics alone do not explain the full picture. Environmental and behavioral factors have long been suspected, particularly hairstyling practices such as chemical relaxers and heat styling. However, the evidence here is genuinely mixed. While certain hairstyling practices clearly contribute to traction alopecia, a different condition caused by pulling on hair follicles, their role in CCCA specifically is less certain.8PubMed. Updates on disorders in curly hair This matters because patients with CCCA have historically been told their styling choices caused the disease, a framing that is oversimplified and can feel dismissive of a condition with real biological roots.
How CCCA Is Diagnosed
Diagnosing CCCA usually involves a combination of clinical examination, dermoscopy (a magnified view of the scalp), and sometimes a scalp biopsy. Dermoscopy has become an increasingly useful tool because it can pick up features invisible to the naked eye. One of the most reliable findings is a whitish-gray halo around the emergence point of individual hairs. In one study, this feature, which corresponds to scarring around the outer root sheath of the follicle, was present in 94% of CCCA patients and was both highly specific and sensitive across all clinical stages of the disease.9PubMed. Dermatoscopic features of central centrifugal cicatricial alopecia
Other dermoscopic signs include a loss of follicular openings in the center of the affected area, pinpoint white dots (representing the scar tissue that has replaced follicles), and, at the active edges of hair loss, broken hairs and follicular irregularity. A scalp biopsy can confirm the diagnosis by showing the characteristic pattern of inflammation around the follicle, particularly at the level of the inner root sheath, followed by replacement of the follicle with scar tissue. Biopsy is especially important when the clinical picture overlaps with other conditions.
Until recently, there was no standardized way to track how severe a person’s CCCA was or whether it was responding to treatment. A photographic scale was developed to capture the pattern and severity of central hair loss in community settings.10PubMed. Central scalp alopecia photographic scale in African American women More recently, a clinical assessment tool called the C-CAT was introduced to quantify symptom severity and help guide treatment decisions in a more structured way.11Skin Appendage Disorders. Using Disease Symptomatology to Guide Treatment in Patients with Central Centrifugal Cicatricial Alopecia: Introduction of C-CAT Scoring Tool These tools are still relatively new, but they represent a shift toward more consistent monitoring of a disease that has historically been managed in an ad hoc fashion.
Telling CCCA Apart From Other Types of Hair Loss
The biggest source of diagnostic confusion is androgenetic alopecia, the common hereditary thinning that affects both men and women. In women, androgenetic alopecia often produces thinning centered on the crown, which can look nearly identical to early CCCA. In men, the overlap is even trickier because male-pattern baldness at the vertex is so expected that clinicians may not consider a scarring process.4PubMed Central. Differentiating central centrifugal cicatricial alopecia and androgenetic alopecia in african american men: report of three cases
A few clues help separate the two. In CCCA, the scalp in the center of the affected area will typically look smooth with no visible follicular openings, whereas in androgenetic alopecia the follicles are miniaturized but still present. Symptoms like burning, tenderness, and itching are much more common in CCCA. And on biopsy, the two conditions look fundamentally different: androgenetic alopecia shows follicle miniaturization without scarring, while CCCA shows inflammatory destruction and fibrosis replacing follicular structures. If you are experiencing thinning at the crown along with scalp discomfort, it is worth asking your dermatologist specifically about CCCA rather than accepting a default diagnosis of pattern hair loss.
Standard Treatment Approaches
The primary goal of CCCA treatment is to stop the inflammatory process before more follicles are destroyed. Because scarred follicles cannot regenerate, early intervention makes a meaningful difference in how much hair a person retains over time. The standard first-line therapies are topical and intralesional corticosteroids, which reduce inflammation directly at the affected follicles, paired with tetracycline-class antibiotics taken by mouth, which have anti-inflammatory properties beyond their antibacterial effects.12PubMed. Beyond the Hot Comb: Updates in Epidemiology, Pathogenesis, and Treatment of Central Centrifugal Cicatricial Alopecia from 2011 to 2021
Intralesional steroid injections, typically given every four to six weeks, target the active border of hair loss where inflammation is most intense. Topical steroids can be applied at home between injection visits. Doxycycline is the most commonly used oral antibiotic for CCCA, prescribed not to treat infection but to dampen the immune-mediated destruction of follicles. Treatment often needs to continue for months or even years, and many dermatologists manage the disease as a chronic condition requiring ongoing maintenance therapy rather than a problem that resolves with a single course.
Minoxidil, the over-the-counter hair growth promoter, is sometimes added as an adjunct. While it does not address the scarring itself, it can help thicken remaining hairs and potentially extend the lifespan of follicles that are not yet fully destroyed. Patients are also generally advised to minimize tension and chemical treatments on the scalp, though as noted earlier, the evidence that these practices directly cause CCCA is not definitive.
Emerging and Experimental Therapies
One of the more intriguing developments in recent years is topical metformin, a drug best known for its use in type 2 diabetes. A case report described visible hair regrowth in two patients with treatment-resistant CCCA after applying a compounded 10% metformin cream.13PubMed Central. Hair regrowth in 2 patients with recalcitrant central centrifugal cicatricial alopecia after use of topical metformin Subsequent case series have used topical metformin alongside standard therapies and reported further regrowth, with researchers proposing that metformin’s anti-fibrotic properties and its effects on androgen levels may both play a role.14PubMed Central. Adjuvant use of topical metformin with standard therapies in recalcitrant central centrifugal cicatricial alopecia: A case series This is still very early-stage evidence, limited to small numbers of patients, and there are no randomized trials yet. But the results have generated real excitement in the dermatology community, particularly because metformin is inexpensive and well-tolerated.
Low-level light therapy, which uses specific wavelengths of red or near-infrared light applied to the scalp, has also shown some early promise. Case reports have described reduced inflammation and hair regrowth in CCCA patients treated with these devices.15PubMed Central. The Use of Light-Based Therapies in the Treatment of Alopecia Platelet-rich plasma injections, in which a concentrated preparation of the patient’s own blood platelets is injected into the scalp, represent another avenue under investigation. All of these approaches need larger, controlled studies before they become routine recommendations, but they offer options for people who have not responded adequately to steroids and antibiotics alone.
Hair Transplantation for Advanced CCCA
For people with end-stage CCCA, where the inflammation has burned out and left behind a stable area of scarring with no remaining active disease, hair transplantation is an option. A study evaluating the procedure in African American women with end-stage CCCA found it to be safe and well-tolerated, provided that scalp biopsy confirmed the absence of ongoing inflammation before surgery.16PubMed. Hair transplantation in the surgical treatment of central centrifugal cicatricial alopecia Transplanting into actively inflamed tissue risks destroying the transplanted follicles, which is why careful patient selection and pre-surgical biopsy are critical.
Hair transplantation does not stop the disease; it addresses the cosmetic aftermath once the disease has stopped itself or been successfully controlled. For people who have been left with a large area of permanent hair loss after years of CCCA, it can be a meaningful option for restoring coverage and confidence. The procedure is expensive and not typically covered by insurance, which limits access for many patients.
Health Conditions Linked to CCCA
Research has increasingly identified that people with CCCA carry a higher burden of certain other health conditions compared to the general population. A retrospective multi-site study found that patients with scarring alopecia, including CCCA, had elevated rates of vitamin D deficiency, metabolic syndrome, depression, anxiety, thyroid disease, uterine fibroids, and anemia.17JEADV Clinical Practice. Comorbidities of Primary Scarring Alopecias: A Retrospective Multi‐Site Cross‐Sectional Study A systematic review and meta-analysis specifically looking at CCCA found a statistically significant association with uterine fibroids, with roughly double the odds compared to controls, though the studies pooled together used different methods of identifying fibroids, making the precise estimate uncertain.18PubMed Central. Systemic Comorbidities in Central Centrifugal Cicatricial Alopecia: A Systematic Review and Meta-analysis
The reasons for these associations are not fully understood. Some of them, like the link with uterine fibroids, may point to shared hormonal or inflammatory pathways. Others, like the elevated rates of depression and anxiety, could be consequences of living with visible hair loss. Regardless of the direction of causality, these findings suggest that clinicians seeing CCCA patients should screen for related conditions and that patients themselves should be aware of the broader health picture.
The Emotional Weight of CCCA
Hair loss of any kind can be distressing, but CCCA carries particular emotional weight. It disproportionately affects Black women, for whom hair often carries deep cultural significance and is intertwined with identity, self-expression, and social perception. A preliminary quality-of-life study found that CCCA had a significant impact on overall well-being, encompassing self-image, social functioning, and day-to-day emotional health.19PubMed Central. Quality of life in patients with central centrifugal cicatricial alopecia: a preliminary study
There is also a longstanding history of dismissiveness around CCCA in clinical settings. Because it was once attributed almost entirely to styling practices, many patients have described feeling blamed for their condition rather than taken seriously. The evolving understanding of CCCA as a disease with genetic and immune-mediated components is slowly shifting this dynamic, but the stigma lingers. If you are dealing with CCCA, finding a dermatologist who specializes in hair loss, ideally one experienced with textured hair, can make a substantial difference in both the quality of care and the clinical relationship. Support groups, both in-person and online, have also become an important resource for people navigating the condition.
Why Early Screening Matters for Textured Hair
One of the most persistent challenges with CCCA is that it is often caught late. The early stages can be subtle, especially in people with dense, coily hair that naturally provides coverage over the crown. By the time the bald area becomes visible, significant follicular destruction may have already occurred. The development of photographic scales designed specifically for central hair loss patterns in Black women was motivated by exactly this problem: the need to identify CCCA earlier, outside of specialty clinics, before irreversible scarring has spread.10PubMed. Central scalp alopecia photographic scale in African American women
If you or your hairstylist notice thinning at the crown, especially if it is accompanied by any tenderness, itching, or a smooth appearance of the exposed scalp, seeking evaluation sooner rather than later is the single most impactful step. CCCA is a condition where the passage of time genuinely works against you. The follicles that are still intact when treatment begins are the ones most likely to survive. Waiting until the bald patch is large and the symptoms are severe means accepting that a substantial amount of permanent damage has already been done.